Related Experiment Video
Updated: Jul 19, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TGF-beta during human colorectal carcinogenesis: the shift from epithelial to mesenchymal signaling
K Matsuzaki1, T Seki, K Okazaki
1Department of Gastroenterology and Hepatology, Kansai Medical University, 10-15 Fumizonocho, Moriguchi, Osaka, 570-8507, Japan. matsuzak@takii.kmu.ac.jp
Abstract:
Transforming growth factor-beta (TGF-beta) activates not only TGF-beta type I receptor (Tbeta RI) but also c-Jun N-terminal kinase (JNK), converting the mediator Smad3 to two distinct phosphoisoforms: C-terminally phosphorylated Smad3 (pSmad3C) and linker phosphorylated Smad3 (pSmad3L). While Tbeta RI/pSmad3C pathway inhibits growth of normal epithelial cells, the activated mesenchymal cells invade via JNK/pSmad3L pathway. During sporadic human colorectal carcinogenesis, TGF-beta signaling confers a selective advantage upon tumor cells by shifting from epithelial Tbeta RI/pSmad3C pathway to mesenchymal JNK/pSmad3L pathway. Loss of epithelial homeostasis and acquisition of a migratory, mesenchymal phenotype are essential for tumor invasion. In a future, specific inhibition of the JNK/pSmad3L pathway will become a therapy for human colorectal cancer that restores the lost tumor-suppressive function observed in normal colorectal epithelial cells at the expense of effects promoting the aggressive behavior.
Insights
Transforming growth factor-beta (TGF-beta) signaling shifts during colorectal cancer. The JNK/pSmad3L pathway promotes tumor invasion, unlike the Tbeta RI/pSmad3C pathway that inhibits normal cell growth.
Area of Science:
- Cellular signaling pathways
- Molecular mechanisms of cancer
- Colorectal carcinogenesis
Background:
- Transforming growth factor-beta (TGF-beta) is a key regulator of cell behavior.
- TGF-beta signaling involves Tbeta RI and JNK pathways, phosphorylating Smad3 into distinct forms.
- Dysregulation of TGF-beta signaling contributes to cancer development.
Purpose of the Study:
- To investigate the role of TGF-beta signaling pathways in human colorectal carcinogenesis.
- To differentiate the functions of Tbeta RI/pSmad3C and JNK/pSmad3L pathways in epithelial and mesenchymal cells.
- To explore potential therapeutic targets for colorectal cancer.
Main Methods:
- Analysis of TGF-beta signaling components and Smad3 phosphoisoforms.
- Investigation of pathway activation in normal epithelial and mesenchymal cells.
- Correlation of pathway shifts with colorectal tumor progression.
Main Results:
- TGF-beta activates both Tbeta RI/pSmad3C and JNK/pSmad3L pathways.
- The Tbeta RI/pSmad3C pathway inhibits normal epithelial cell growth.
- The JNK/pSmad3L pathway promotes mesenchymal cell invasion, crucial for colorectal cancer progression.
Conclusions:
- TGF-beta signaling shifts from a tumor-suppressive to a tumor-promoting role during colorectal carcinogenesis.
- The JNK/pSmad3L pathway is essential for tumor cell invasion and aggressive behavior.
- Targeting the JNK/pSmad3L pathway may restore tumor-suppressive functions and offer a novel therapy for colorectal cancer.
Related Concept Videos
TGF - β Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

